🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, multicenter, two-arm, noncomparative, phase II study ...
Status
Unknown
Location
Affiliated Tumor Hospital of Guangxi Medical University.
Start Date
2023-12-10
Trial ID
NCT06161272
Treatments Being Tested
The purpose of this study is to establish a prospective, single-center plat...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center Shanghai, China, 200032
Start Date
2022-11-01
Trial ID
NCT05582499
Treatments Being Tested
This multicenter, open-label, prospective cohort clinical study enrolled 70...
Status
Terminated
Location
Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences
Start Date
2025-07-01
Trial ID
NCT07000344
Treatments Being Tested
This study is a Phase II single-arm, open label, multicenter study to acces...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-10-30
Trial ID
NCT06081595
Treatments Being Tested
The study is being conducted to evaluate the tolerability, safety and effic...
Status
Completed
Location
Beijing Cancer Hosptial
Start Date
2019-06-04
Trial ID
NCT03945604
Treatments Being Tested
This study is a Phase II randomized, open label, controlled, multicenter st...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-08-01
Trial ID
NCT05479487
Treatments Being Tested
This study is a prospective, open-label, multicenter, randomized controlled...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2025-04-08
Trial ID
NCT06913777
This open-label, dose finding phase Ib trial studies the tolerability and t...
Status
Unknown
Location
Tianjin Medical University Second Hospital
Start Date
2020-07-01
Trial ID
NCT04659785
Treatments Being Tested
Main research purpose: To evaluate the effectiveness of Fluzoparib combined...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2021-07-19
Trial ID
NCT04869488
Thirty-seven women aged 18-75 years with recurrent ovarian cancer were enro...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-12-01
Trial ID
NCT06188455
Treatments Being Tested